Literature DB >> 25240260

The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling.

Karen Wagner1, Steve Vito1, Bora Inceoglu1, Bruce D Hammock2.   

Abstract

Lipid derived mediators contribute to inflammation and the sensing of pain. The contributions of omega-6 derived prostanoids in enhancing inflammation and pain sensation are well known. Less well explored are the opposing anti-inflammatory and analgesic effects of the omega-6 derived epoxyeicosatrienoic acids. Far less has been described about the epoxidized metabolites derived from omega-3 long chain fatty acids. The epoxide metabolites are turned over rapidly with enzymatic hydrolysis by the soluble epoxide hydrolase being the major elimination pathway. Despite this, the overall understanding of the role of lipid mediators in the pathology of chronic pain is growing. Here, we review the role of long chain fatty acids and their metabolites in alleviating both acute and chronic pain conditions. We focus specifically on the epoxidized metabolites of omega-6 and omega-3 long chain fatty acids as well as a novel strategy to modulate their activity in vivo. Published by Elsevier Inc.

Entities:  

Keywords:  EpDPEs); Epoxy fatty acids (EpFAs); Epoxydocosapentanoic acids (EDP; Epoxyeicosatrienoic acids (EETs); Omega-3 fatty acids; Pain; Soluble epoxide hydrolase (sEH)

Mesh:

Substances:

Year:  2014        PMID: 25240260      PMCID: PMC4254344          DOI: 10.1016/j.prostaglandins.2014.09.001

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  116 in total

Review 1.  Evolutionary aspects of diet and essential fatty acids.

Authors:  A P Simopoulos
Journal:  World Rev Nutr Diet       Date:  2001       Impact factor: 0.575

2.  Conditioned place preference reveals tonic pain in an animal model of central pain.

Authors:  Leyla Davoody; Raimi L Quiton; Jessica M Lucas; Yadong Ji; Asaf Keller; Radi Masri
Journal:  J Pain       Date:  2011-04-23       Impact factor: 5.820

Review 3.  Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia.

Authors:  Korapat Mayurasakorn; Jill J Williams; Vadim S Ten; Richard J Deckelbaum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2011-03       Impact factor: 4.294

4.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway.

Authors:  Robert Fischer; Anne Konkel; Heidrun Mehling; Katrin Blossey; Andrej Gapelyuk; Niels Wessel; Clemens von Schacky; Ralf Dechend; Dominik N Muller; Michael Rothe; Friedrich C Luft; Karsten Weylandt; Wolf-Hagen Schunck
Journal:  J Lipid Res       Date:  2014-03-16       Impact factor: 5.922

5.  Molecular characterization of an arachidonic acid epoxygenase in rat brain astrocytes.

Authors:  N J Alkayed; J Narayanan; D Gebremedhin; M Medhora; R J Roman; D R Harder
Journal:  Stroke       Date:  1996-05       Impact factor: 7.914

6.  Prostaglandins, aspirin-like drugs and analgesia.

Authors:  S H Ferreira
Journal:  Nat New Biol       Date:  1972-12-13

7.  Role of epoxyeicosatrienoic acids as autocrine metabolites in glutamate-mediated K+ signaling in perivascular astrocytes.

Authors:  Haruki Higashimori; Víctor M Blanco; Vengopal Raju Tuniki; John R Falck; Jessica A Filosa
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-15       Impact factor: 4.249

8.  The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expression.

Authors:  Xingjia Wang; Chwan-Li Shen; Matthew T Dyson; Xianling Yin; Randolph B Schiffer; Paula Grammas; Douglas M Stocco
Journal:  J Endocrinol       Date:  2006-09       Impact factor: 4.286

Review 9.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

Review 10.  Deconstructing the neuropathic pain phenotype to reveal neural mechanisms.

Authors:  Christian A von Hehn; Ralf Baron; Clifford J Woolf
Journal:  Neuron       Date:  2012-02-23       Impact factor: 17.173

View more
  29 in total

1.  Epoxy fatty acids mediate analgesia in murine diabetic neuropathy.

Authors:  K Wagner; K S S Lee; J Yang; B D Hammock
Journal:  Eur J Pain       Date:  2016-09-15       Impact factor: 3.931

Review 2.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

Review 3.  Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Authors:  Milan Fiala; Gijs Kooij; Karen Wagner; Bruce Hammock; Matteo Pellegrini
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

4.  High-Oleic Ready-to-Use Therapeutic Food Maintains Docosahexaenoic Acid Status in Severe Malnutrition.

Authors:  Ji-Cheng Hsieh; Lei Liu; Mamane Zeilani; Scott Ickes; Indi Trehan; Ken Maleta; Christina Craig; Chrissie Thakwalakwa; Lauren Singh; J Thomas Brenna; Mark J Manary
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-07       Impact factor: 2.839

Review 5.  Modulation of mitochondrial dysfunction and endoplasmic reticulum stress are key mechanisms for the wide-ranging actions of epoxy fatty acids and soluble epoxide hydrolase inhibitors.

Authors:  Bora Inceoglu; Ahmed Bettaieb; Fawaz G Haj; Aldrin V Gomes; Bruce D Hammock
Journal:  Prostaglandins Other Lipid Mediat       Date:  2017-08-25       Impact factor: 3.072

6.  Cytochrome P450 monooxygenase lipid metabolites are significant second messengers in the resolution of choroidal neovascularization.

Authors:  Eiichi Hasegawa; Saori Inafuku; Lama Mulki; Yoko Okunuki; Ryoji Yanai; Kaylee E Smith; Clifford B Kim; Garrett Klokman; Diane R Bielenberg; Narender Puli; John R Falck; Deeba Husain; Joan W Miller; Matthew L Edin; Darryl C Zeldin; Kin Sing Stephen Lee; Bruce D Hammock; Wolf-Hagen Schunck; Kip M Connor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

7.  Peroxisomal translocation of soluble epoxide hydrolase protects against ischemic stroke injury.

Authors:  Jonathan W Nelson; Wenri Zhang; Nabil J Alkayed; Ines P Koerner
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-01       Impact factor: 6.200

8.  Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.

Authors:  Qian Ren; Min Ma; Jun Yang; Risa Nonaka; Akihiro Yamaguchi; Kei-Ichi Ishikawa; Kenta Kobayashi; Shigeo Murayama; Sung Hee Hwang; Shinji Saiki; Wado Akamatsu; Nobutaka Hattori; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-07       Impact factor: 11.205

Review 9.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

10.  Gene deficiency and pharmacological inhibition of soluble epoxide hydrolase confers resilience to repeated social defeat stress.

Authors:  Qian Ren; Min Ma; Tamaki Ishima; Christophe Morisseau; Jun Yang; Karen M Wagner; Ji-Chun Zhang; Chun Yang; Wei Yao; Chao Dong; Mei Han; Bruce D Hammock; Kenji Hashimoto
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.